GPR40: A therapeutic target for mediating insulin secretion (Review)

W YangJ LuJ WengPrevalence of diabetes among men and women in ChinaN Engl J Med36210901101201010.1056/NEJMoa090829220335585

TM DavisKE PetersDG BruceWA DavisPrevalence, incidence and prognosis of hepatobiliary disease in community-based patients with type 2 diabetes: the Fremantle Diabetes StudyJ Clin Endocrinol Metab9715811588201210.1210/jc.2011-323222362822

JC HenquinTriggering and amplifying pathways of regulation of insulin secretion by glucoseDiabetes4917511760200010.2337/diabetes.49.11.175111078440

Y SakoV GrillA 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidationEndocrinology12715801589199010.1210/endo-127-4-15801698143

G AyvazF Balos TörünerA KarakoçAcute and chronic effects of different concentrations of free fatty acids on the insulin secreting function of isletsDiabetes Metab283S73S12200212688627

J SchmidtK LiebscherN MertenConjugated linoleic acids mediate insulin release through islet G protein-coupled receptor FFA1/GPR40J Biol Chem2861189011894201110.1074/jbc.C110.20047721339298

S KashyapR BelfortA GastaldelliA sustained increase in plasma free fatty acids impairs insulin secretion in non-diabetic subjects genetically predisposed to develop type 2 diabetesDiabetes5224612474200310.2337/diabetes.52.10.2461

B Ritz-LaserP MedaI ConstantGlucose-induced preproinsulin gene expression is inhibited by the free fatty acid palmitateEndocrinology14040054014199910465270

KS GwiazdaTL YangY LinJD JohnsonEffects of palmitate on ER and cytosolic Ca²⁺ homeostasis in β-cellsAm J Physiol Endocrinol Metab296E690E701200910.1152/ajpendo.90525.200819141690

E LaiG BikopoulosMB WheelerDifferential activation of ER stress and apoptosis in response to chronically elevated free fatty acids in pancreatic beta-cellsAm J Physiol Endocrinol Metab294E540E550200810.1152/ajpendo.00478.200718198352

M Böni-SchnetzlerS BollerS DebrayFree fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor IEndocrinology15052185229200919819943

Y TuoDD FengDF WangLong-term in vitro treatment of INS-1 rat pancreatic β-cells by unsaturated free fatty acids protects cells against gluco- and lipotoxicities via activation of GPR40 receptorsClin Exp Pharmacol Physiol394234282012

A ChawlaJJ RepaRM EvansDJ MangelsdorfNuclear receptors and lipid physiology: opening the X-filesScience29418661870200110.1126/science.294.5548.186611729302

M SawzdargoSR GeorgeT NguyenA cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1Biochem Biophys Res Commun239543547199710.1006/bbrc.1997.75139344866

AJ BrownSM GoldsworthyAA BarnesThe Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acidsJ Biol Chem2781131211319200310.1074/jbc.M21160920012496283

S SchnellM SchaeferC SchoflFree fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40Mol Cell Endocrinol263173180200710.1016/j.mce.2006.09.01317101212

S MiyauchiA HirasawaA IchimuraNew frontiers in gut nutrient sensor research: free fatty acid sensing in the gastrointestinal tractJ Pharmacol Sci1121924201010.1254/jphs.09R09FM20093784

Y XiongN MiyamotoK ShibataShort-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41Proc Natl Acad Sci USA10110451050200410.1073/pnas.263700210014722361

E Le PoulC LoisonS StruyfFunctional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activationJ Biol Chem2782548125489200312711604

H GeX LiJ WeiszmannActivation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acidsEndocrinology14945194526200810.1210/en.2008-005918499755

KM MaslowskiAT VieiraA NgRegulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43Nature46112821286200910.1038/nature0853019865172

A HirasawaK TsumayaT AwajiFree fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120Nat Med119094200510.1038/nm116815619630

DY OhS TalukdarEJ BaeGPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effectsCell142687698201010.1016/j.cell.2010.07.04120813258

M KebedeT AlquierMG LatourThe fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feedingDiabetes5724322437200810.2337/db08-055318559658

S Del GuerraM BuglianiV D’AleoG-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acidsNutr Metab Cardiovasc Dis202225201019758793

T AlquierML PeyotMG LatourDeletion of GPR40 impairs glucose-induced insulin secretion in vivo in mice without affecting intracellular fuel metabolism in isletsDiabetes5826072615200910.2337/db09-036219720802

K NagasumiR EsakiK IwachidowOverexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic miceDiabetes5810671076200910.2337/db08-123319401434

JB HouzeL ZhuY SunAMG 837: a potent, orally bioavailable GPR40 agonistBioorg Med Chem Lett2212671270201210.1016/j.bmcl.2011.10.11822217876

N NegoroS SasakiM ItoIdentification of fused-ring alkanoic acids with improved pharmacokinetic profiles that act as G protein-coupled receptor 40/free fatty acid receptor 1 agonistsJ Med Chem5515381552201210.1021/jm201296822242551

T HaraA HirasawaA IchimuraFree fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disordersJ Pharm Sci10035943601201110.1002/jps.2263921618241

Y ItohS HinumaGPR40, a free fatty acid receptor on pancreatic beta cells, regulates insulin secretionHepatol Res33171173200516214394

T TomitaH MasuzakiM NoguchiGPR40 gene expression in human pancreas and insulinomaBiochem Biophys Res Commun33817881790200510.1016/j.bbrc.2005.10.16116289108

P StenebergN RubinsR Bartoov-ShifmanThe FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouseCell Metab1245258200510.1016/j.cmet.2005.03.00716054069

R Bartoov-ShifmanG RidnerK BaharRegulation of the gene encoding GPR40, a fatty acid receptor expressed selectively in pancreatic beta cellsJ Biol Chem2822356123571200710.1074/jbc.M70211520017525159

G RidnerR Bartoov-ShifmanT ZaloginRegulation of the GPR40 locus: towards a molecular understandingBiochem Soc Trans36360362200810.1042/BST036036018481958

MS WinzellB AhrénG-protein-coupled receptor and islet function-implications for treatment type 2 diabetesPharmacol Ther116437448200710.1016/j.pharmthera.2007.08.00217900700

LA StoddartNJ SmithG MillganInternational Union of Pharmacology. LXXI Free fatty acid receptor FFA1, -2, and -3: pharmacology and pathophysiological functionsPharmacol Rev60405417200810.1124/pr.108.0080219047536

IG TikhonovaCS SumS NeumannBidirectional, iterative approach to the structural delineation of the functional ‘chemoprint’ in GPR40 for agonist recognitionJ Med Chem5029812989200717552505

NG MorganS DhayalG-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta cellBiochem Pharmacol7814191427200910.1016/j.bcp.2009.07.02019660440

CS SumIG TikhonovaS NeumannIdentification of residues important for agonist recognition and activation in GPR40J Biol Chem2822924829255200710.1074/jbc.M70507720017699519

SY LuYJ JiangJW ZouInsight into analysis of interactions of GW9508 to wild-type and H86F and H137F GPR40: a combined QM/MM study and pharmacophore modelingJ Mol Graph Model29818825201110.1016/j.jmgm.2011.01.00621334233

T OgawaH HiroseK MiyashitaGPR40 gene Arg211His polymorphism may contribute to the variation of insulin secretory capacity in Japanese menMetabolism54296299200510.1016/j.metabol.2004.09.00815736105

R VettorM GranzottoD De StefaniLoss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilizationJ Clin Endocrinol Metab9335413550200810.1210/jc.2007-2680

CP BriscoeM TadayyonJL AndrewsThe orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acidsJ Biol Chem2781130311311200310.1074/jbc.M21149520012496284

Y ItohY KawamataM HaradaFree fatty acids regulate insulin secretion from pancreatic beta cells through GPR40Nature422173176200310.1038/nature0147812629551

K KotarskyNE NilssonE FlodgrenA human cell surface receptor activated by free fatty acids and thiazolidinedione drugsBiochem Biophys Res Commun301406410200310.1016/S0006-291X(02)03064-412565875

M YangJW ChisholmS SoelaimanJC ShryockSulfonylureas uncouple glucose-dependence for GPR40-mediated enhancement of insulin secretion from INS-1E cellsMol Cell Endocrinol315308313201010.1016/j.mce.2009.09.033

R YazakiN KumagaiM ShibasakiEnantioselective synthesis of a GPR40 agonist AMG 837 via catalytic asymmetric conjugate addition of terminal alkyne to α,β-unsaturated thioamideOrg Lett13952955201121291204

R YazakiN KumagaiM ShibasakiCooperative activation of alkyne and thioamide functionalities; direct catalytic asymmetric conjugate addition of terminal alkynes to α,β-unsaturated thioamidesChem Asian J617781790201121538905

SP WalshA SeverinoC Zhou3-Substituted 3-(4-aryloxyaryl)-propanoic acids as GPR40 agonistsBioorg Med Chem Lett2133903394201110.1016/j.bmcl.2011.03.11421514824

X ZhangG YanY LiDC260126, a small-molecule antagonist of GPR40, improves insulin tolerance but not glucose tolerance in obese Zucker ratsBiomed Pharmacother64647651201010.1016/j.biopha.2010.06.00820888730

H HuLY HeZ GongA novel class of antagonists for the FFAs receptor GPR40Biochem Biophys Res Commun390557563200910.1016/j.bbrc.2009.10.00419818732

J WuP SunX ZhangInhibition of GPR40 protects MIN6 β cells from palmitate-induced ER stress and apoptosisJ Cell Biochem113115211582012

Y ZhaoY SongX ShenJ LiaoFeasible synthesis of antagonist of GPR40 by constructing 2-thiouracil ring via acid mediated cyclizationHeterocycles8311451151201110.3987/COM-11-1217521776181

DT SteinV EsserBE StevensonEssentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted ratJ Clin Invest9727282735199610.1172/JCI1187278675683

VC TueiJS HaCE HaEffects of human serum albumin complexed with free fatty acids on cell viability and insulin secretion in the hamster pancreatic β-cell line HIT-T15Life Sci88810818201121396379

C WangH TanH YuImpairment of insulin action in non-obese, normal-glucose tolerant, first-degree relatives of Chinese type 2 diabetic patientsDiabetes Res Clin Pract916771201110.1016/j.diabres.2010.10.00121051097

H LanLM HoosL LiuLack of FFAR1/GPR40 does not protect mice from high-fat diet-induced metabolic diseaseDiabetes5729993006200810.2337/db08-059618678612

CP TanY FengYP ZhouSelective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in miceDiabetes5722112219200810.2337/db08-013018477808

K FujiwaraF MaekawaT YadaOleic acid interacts with GPR40 to induce Ca²⁺ signaling in rat islet beta-cells: mediation by PLC and L-type Ca²⁺ channel and link to insulin releaseAm J Physiol Endocrinol Metab289E670E677200515914509

H ShapiroS ShacharI SeklerRole of GPR40 in fatty acid action on the beta cell line INS-1EBiochem Biophys Res Commun33597104200510.1016/j.bbrc.2005.07.04216081037

MG LatourT AlquierE OseidGPR40 in necessary but not sufficient for fatty acid stimulation of insulin secretion in vivoDiabetes5610871094200710.2337/db06-153217395749

DD FengZ LuoSG RohReduction in voltage-gated K⁺ currents in primary cultured rat pancreatic beta-cells by linoleic acidsEndocrinology1476746822006

CP BriscoeAJ PeatSC McKeownPharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small moleculesBr J Pharmacol148619628200610.1038/sj.bjp.070677016702987

S MikamiS KitamuraN NegoroDiscovery of phenylpropanoic acid derivatives containing polar functionalities as potent and orally bioavailable G protein-coupled receptor 40 agonists for the treatment of type 2 diabetesJ Med Chem5537563776201210.1021/jm2016123

DC LinJ ZhangR ZhuangAMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodentsPLoS One6e27270201110.1371/journal.pone.002727022087278

P WuL YangX ShenThe relationship between GPR40 and lipotoxicity of the pancreatic β-cells as well as the effect of pioglitazoneBiochem Biophys Res Commun40336392010

S Meidute AbaravicieneI LundquistJ GalvanovskisPalmitate-induced beta-cell dysfunction is associated with excessive NO production and is reversed by thiazolidinedione-mediated inhibition of GPR40 transduction mechanismsPLoS One3e2182200818478115

S SinghYK LokeCD FurbergThiazolidinediones and heart failure: a teleo-analysisDiabetes Care3021482153200710.2337/dc07-014117536074

A MieczkowskaMF BasleD ChappardG MabilleauThiazolidinediones induced osteocyte apoptosis by a G protein-coupled receptor 40-dependent mechanismJ Biol Chem2872351723526201210.1074/jbc.M111.32481422593579

C ZhouC TangE ChangDiscovery of 5-aryloxy-2,4-thiazolidinediones as potent GPR40 agonistsBioorg Med Chem Lett2012981301201010.1016/j.bmcl.2009.10.05220064714

H YashiroY TsujihataK TakeuchiThe effects of TAK-875, a selective G protein-coupled receptor 40/free fatty acid 1 agonist, on insulin and glucagon secretion in isolated rat and human isletsJ Pharmacol Exp Ther340483489201210.1124/jpet.111.18770822106100

Y TsujihataR ItoM SuzukiTAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic ratsJ Pharmacol Exp Ther339228237201110.1124/jpet.111.183772

N NegoroS SasakiS MikamiOptimization of (2,3-dihydro-1-benzofuran-3-yl)acetic acids: discovery of a non-free fatty acid-like, highly bioavailable G protein-coupled receptor 40/free fatty acid receptor 1 agonist as a glucose-dependent insulinotropic agentJ Med Chem5539603974201210.1021/jm300170m

H NaikM VakilynejadJ WuSafety, tolerability, pharmacokinetics, and pharmacodynamic properties of the GPR40 agonist TAK-875: results from a double-blind, placebo-controlled single oral dose rising study in healthy volunteersJ Clin Pharmacol5210071016201210.1177/0091270011409230

T ArakiM HirayamaS HiroiK KakuGPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetesDiabetes Obes Metab14271278201210.1111/j.1463-1326.2011.01525.x22051148

CF BurantP ViswanathanJ MarcinakTAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trialLancet37914031411201210.1016/S0140-6736(11)61879-522374408

W XieY ZhaoY ZhangTraditional chinese medicines in treatment of patients with type 2 diabetes mellitusEvid Based Complement Alternat Med2011726723201121584252

M ChaoD ZouY ZhangImproving insulin resistance with traditional Chinese medicine in type 2 diabetic patientsEndocrine36268274200910.1007/s12020-009-9222-y19728183

DS ChenB KeYJ HuangEffects of the modified linggui zhugan decoction (see text) combined with short-term very low calorie diets on glycemic control in newly diagnosed type 2 diabeticsJ Tradit Chin Med31185188201110.1016/S0254-6272(11)60038-121977859

AF CiceroE TartagniAntidiabetic properties of berberine: from cellular pharmacology to clinical effectsHosp Pract (Minneap)405663201210.3810/hp.2012.04.97022615079

T LouZ ZhangZ XiBerberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytesInflammation34659667201110.1007/s10753-010-9276-221110076

N GaoTY ZhaoXJ LiThe protective effect of berberine on β-cell lipoapoptosisJ Endocrinol Invest341241302011

BS KoSB ChoiSK ParkInsulin sensitizing and insulinotropic action of berberine from Cortidis rhizomaBiol Pharm Bull2814311437200510.1248/bpb.28.143116079488

GV RayasamVK TulasiS SundaramIdentification of berberine as a novel agonist of fatty acid receptor GPR40Phytother Res2412601263201020658575

SM ParkSM HongSR SungExtracts of Rehmanniae radix, Ginseng radix and Scutellariae radix improve glucose-stimulated insulin secretion and beta-cell proliferation through IRS2 inductionGenes Nutr23473512008

Y ZhangD LiuFlavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory functionEur J Pharmacol670325332201110.1016/j.ejphar.2011.08.01121914439

S EdfalkP StenebergH EdlundGpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretionDiabetes5722802287200810.2337/db08-030718519800

N KruskaG ReiserPhytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca²⁺ signaling through activation of free fatty acid receptor GPR40Neurobiol Dis43465472201110.1016/j.nbd.2011.04.020

K NakamotoT NishinakaK MatsumotoInvolvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory systemBrain Res14327483201210.1016/j.brainres.2011.11.012